glp-1 agonists and muscle loss therapies lead to weight mainly from fat, but a portion includes muscle. Similar patterns are seen with lifestyle based weight loss. https://t.co/5KtH19evB0 #MedTwitter #ObesityMedicine #GLP1 #ClinicalResearch The GLP-1 Agonists and Obesity:

How GHK-Cu Levels Change With Age GHK-Cu levels decline steadily throughout adulthood, with plasma concentrations dropping by more than half between early adulthood and older age

It appears that reduced plasma and peripheral tissue carnitine levels result from sequestration by ethanol-compromised liver [71]

Glutamine, but not leucine, was found to activate mTORC1 by a pathway requiring the ADP ribosylation factor-1 GTPase and vacuolar adenosine triphosphatase for mTORC1 translocation and fixation, respectively, to the lysosomal membrane

The two primary variants are the newer tirzepatide (sold under the brand names Zepbound and Mounjaro) and more established semaglutide (sold under the brand names Rybelsus, Ozempic and Wegovy)